[Topical treatment with mitomycin C in considerably raised conjunctival intraepithelial neoplasia].
METHODS
We present a case of recurrent conjunctival intraepithelial neoplasia, treated previously on two occasions with excisional biopsy. Although the lesion was considerably raised, topical treatment with mitomycin-C 0.04% was applied, achieving the complete regression of the tumor.


CONCLUSIONS
Topical mitomycin-C acts at the ocular surface. However, successive treatment cycles can achieve complete regression, even in considerably thick tumors.
Rodríguez-Pérez
C
C
Servicio de Oftalmología, Hospital de la Santa Creu i Sant Pau, Barcelona, España.
Del Campo
Z
Z
Wolley-Dod
C
C
Gris
O
O
D000287:Administration, Topical; D000368:Aged; D000369:Aged, 80 and over; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D002278:Carcinoma in Situ / Q000188:drug therapy* / Q000473:pathology; D003230:Conjunctival Neoplasms / Q000188:drug therapy* / Q000473:pathology; D019573:Epithelium, Corneal / Q000473:pathology; D006801:Humans; D008297:Male; D016685:Mitomycin / Q000627:therapeutic use*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D016896:Treatment Outcome
D000903:Antibiotics, Antineoplastic; D016685:Mitomycin